<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Rate control versus rhythm control in RACE</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Rate control versus rhythm control in RACE</h1>
<div class="graphic"><div class="figure"><div class="ttl">Rate control versus rhythm control in RACE</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Results of the RACE trial in which 522 patients with recurrent persistent atrial fibrillation (AF) were randomly assigned to rhythm or rate control. The primary end point was a composite of cardiovascular death, heart failure, thromboembolism, bleeding, pacemaker placement, and antiarrhythmic drug side effects. There was an almost significant trend toward a lower incidence of the primary end point with rate control (17.2 versus 22.6 percent with rhythm control, hazard ratio 0.73, 90 percent CI 0.53 to 1.01).</div><div class="graphic_reference">Data from Van Gelder IC, Hagens VE, Bosker HA, et al. N Engl J Med 2002; 347:1834.</div><div id="graphicVersion">Graphic 74434 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
